Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cox, D.
Right arrow Articles by Mohr, D. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cox, D.
Right arrow Articles by Mohr, D. C
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Multiple Sclerosis, Vol. 10, No. 6, 626-629 (2004)
DOI: 10.1191/1352458504ms1095oa
© 2004 SAGE Publications

The unique impact of changes in normal appearing brain tissue on cognitive dysfunction in secondary progressive multiple sclerosis patients

Darcy Cox

Department of Neurology, University of California, San Francisco, CA, USA

Daniel Pelletier

Department of Neurology, University of California, San Francisco, CA, USA

Claude Genain

Department of Neurology, University of California, San Francisco, CA, USA

Sharmila Majumdar

Department of Radiology, University of California, San Francisco, CA, USA

Ying Lu

Department of Radiology, University of California, San Francisco, CA, USA

Sarah Nelson

Department of Radiology, University of California, San Francisco, CA, USA

David C Mohr

Department of Neurology, University of California, San Francisco, CA, USA, Department of Psychiatry, University of California, San Francisco, CA, USA, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA, dmohr{at}itsa.ucsf.edu

Objective: The purpose of this study was to examine the relationships between cognitive functioning, whole brain magnetic transfer ratio (MTR) imaging, supratentorial 1H-magnetic resonance spectroscopy imaging (1HMRSI), and conventional T1 and T2 imaging in a homogenous sample of SPMS patients. Methods: Nineteen patients underwent a single 90-min imaging session that obtained T1-and T2-weighted images and MTR. 1HMRSI was obtained on 14 of these patients. Patients underwent a neuropsychological battery, which was used to create an integrated measure of cognitive impairment. Cognitive impairment was the dependent variable in two hierarchical multiple regression analyses in which T2 lesion load, T1 lesion load, and MTR or NAA/Cr were entered sequentially. Results: MTR was significantly related to cognitive functioning ({Delta}R2= 0.22, P= 0.02) after accounting for T2 lesion load ({Delta}R2=0.33, P= 0.01) and T1 lesion load ({Delta}R2= 0.00, P=0.98). NAA/Cr was not significantly related to cognitive functioning. Conclusions: Cognitive dysfunction may act as a clinical marker of normal appearing brain tissue pathology in multiple sclerosis.

Key Words: multiple sclerosis • MRI • cognitive impairment • neuropsychological assessment • spectroscopy • magnetic transfer ratio imaging


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?